Recent News

• 08.26.2025 - Unicycive Therapeutics to Participate in Upcoming Investor Events in September
• 08.18.2025 - Unicycive Therapeutics Granted New U.S. Patent for UNI-494 to Treat Chronic Kidney Disease
• 08.14.2025 - Unicycive Therapeutics Announces Second Quarter 2025 Financial Results and Provides Business Update

Recent Filings

• 08.26.2025 - 4 Statement of changes in beneficial ownership of securities
• 08.18.2025 - 8-K Current report
• 08.15.2025 - 8-K Current report
• 08.14.2025 - 8-K Current report
• 08.14.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 08.14.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 08.14.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 08.14.2025 - EX-99.1 EX-99.1
• 08.14.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 08.12.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors